AFYA Afya Ltd

Nasdaq afya.com.br


$ 14.89 $ -0.23 (-1.52 %)    

Wednesday, 22-Oct-2025 15:59:38 EDT
QQQ $ 604.27 $ -5.89 (-0.96 %)
DIA $ 464.98 $ -3.44 (-0.73 %)
SPY $ 666.76 $ -3.49 (-0.52 %)
TLT $ 92.19 $ 0.06 (0.07 %)
GLD $ 376.01 $ 0.04 (0.01 %)
$ 14.89
$ 15.12
$ 13.05 x 30
$ 16.70 x 145
$ 14.88 - $ 15.13
$ 13.47 - $ 19.90
69,755
na
1.4B
$ 0.84
$ 13.67
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-upgrades-afya-to-buy-lowers-price-target-to-19

UBS analyst Andre Salles upgrades Afya (NASDAQ:AFYA) from Neutral to Buy and lowers the price target from $19.5 to $19.

 jp-morgan-upgrades-afya-to-overweight-raises-price-target-to-245

JP Morgan analyst Marcelo Santos upgrades Afya (NASDAQ:AFYA) from Neutral to Overweight and raises the price target from $23...

 afya-q2-adj-eps-040-beats-038-estimate-sales-16228m-miss-16452m-estimate

Afya (NASDAQ:AFYA) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.38 by 5.53 pe...

 afya-limited-announces-new-share-repurchase-program-for-up-to-4m-class-a-shares

AFYA LIMITED ANNOUNCES A NEW SHARE REPURCHASE PROGRAM Belo Horizonte, Brazil, August 13, 2025 – Afya Limited (NASDAQ:AFYA, B3: ...

 citigroup-upgrades-afya-to-neutral-lowers-price-target-to-14

Citigroup analyst Leandro Bastos upgrades Afya (NASDAQ:AFYA) from Sell to Neutral and lowers the price target from $16 to $14.

 ubs-maintains-neutral-on-afya-raises-price-target-to-195

UBS analyst Andre Salles maintains Afya (NASDAQ:AFYA) with a Neutral and raises the price target from $17.5 to $19.5.

 afya-limiteds-board-approves-engagement-of-kpmg-as-new-independent-auditor

Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medi...

 afya-q1-adj-eps-r320-beats-r275-estimate-sales-r93636m-beat-r92652m-estimate

Afya (NASDAQ:AFYA) reported quarterly earnings of R$3.20 per share which beat the analyst consensus estimate of R$2.75 by 16.36...

 morgan-stanley-downgrades-afya-to-underweight-lowers-price-target-to-17

Morgan Stanley analyst Mauricio Cepeda downgrades Afya (NASDAQ:AFYA) from Equal-Weight to Underweight and lowers the price t...

 citigroup-downgrades-afya-to-sell-lowers-price-target-to-15

Citigroup analyst Leandro Bastos downgrades Afya (NASDAQ:AFYA) from Neutral to Sell and lowers the price target from $18 to ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION